MedTrace Logo

Self Selection Trial of Naproxen Sodium

NCT01383486 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 253

Last updated 2015-10-15

Study results available
· View outcomes & findings →

Summary

A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.

Conditions

Interventions

DRUG

Naproxen sodium ER (BAYH6689)

Naproxen Sodium ER (BAYH6689): oral tablet upon incidence of pain

DRUG

Advil

Commercially available Advil; oral caplet upon incidence of pain

Sponsors & Collaborators

Principal Investigators

  • Bayer Study Director · Bayer

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01383486 on ClinicalTrials.gov